Legal Notice

Legal & Medical Advertising Notice

Self-funded care

Self-funded care (not covered by public insurance)。Fees shown as total out-of-pocket cost.

Disclosure on unapproved medicines/devices

• The processed cell products used in this treatment are unapproved under Japan's Pharmaceuticals and Medical Devices Act.
• Cells are the patient's own, cultured at the clinic's partnered cell-processing facility (procurement route).
• No domestically approved pharmaceutical with the same composition and performance exists.
• No approved equivalent is confirmed in other countries; ask your physician about available safety information.
• This treatment is not covered by Japan's Adverse Drug Reaction Relief System.
• As a self-funded (jiyu-shinryo) treatment, public health insurance does not apply; the full cost is borne by the patient.

Regenerative Medicine Provision Plan

Provided under a provision plan filed with (and accepted by) the authorities pursuant to the Act on the Safety of Regenerative Medicine. Acceptance of a filing is not governmental approval of efficacy.

Main risks & side effects

Reported risks include bruising, swelling or pain at the collection site, fever or allergic reaction during infusion, and, rarely, infection. Results vary between individuals.

About this website

This site is a design and AI-visibility demonstration by Chidori. Treatment and fee details are based on public information — please confirm directly with the clinic.

最終更新日 2026-07-17｜監修：院長 亀井 克彦